{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:38:13Z","timestamp":1779100693608,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T00:00:00Z","timestamp":1527292800000},"content-version":"vor","delay-in-days":145,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/j.rmcr.2018.05.026","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T03:58:47Z","timestamp":1527652727000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Hypoxic respiratory failure due to hyperammonemic encephalopathy induced by concurrent use of valproic acid and topiramate, a case report and review of the literature"],"prefix":"10.1016","volume":"25","author":[{"given":"Yonas","family":"Raru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5287-5691","authenticated-orcid":false,"given":"Fuad","family":"Zeid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmcr.2018.05.026_bib1","doi-asserted-by":"crossref","unstructured":"Adeva, MM. et al. Ammonium metabolism in humans metabolism - Clin. Exp., Volume 61, Issue 11, 1495\u20131511.","DOI":"10.1016\/j.metabol.2012.07.007"},{"key":"10.1016\/j.rmcr.2018.05.026_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ebcr.2014.09.001","article-title":"Topiramate-induced hyperammonemic encephalopathy in a patient with mental retardation: a case report and review of the literature","volume":"4","author":"Tantikittichaikul","year":"2015","journal-title":"Epilepsy Behav. Case Rep."},{"key":"10.1016\/j.rmcr.2018.05.026_bib3","doi-asserted-by":"crossref","unstructured":"Walker, Valerie. Severe hyperammonemia in adults not explained by liver disease. Ann. Clin. Biochem.. Vol 49, Issue 3, pp. 214\u2013228.","DOI":"10.1258\/acb.2011.011206"},{"issue":"03","key":"10.1016\/j.rmcr.2018.05.026_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.genhosppsych.2011.12.009","article-title":"Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management","volume":"34","author":"Chopra","year":"2012","journal-title":"Gen. Hosp. Psychiatr."},{"issue":"9","key":"10.1016\/j.rmcr.2018.05.026_bib5","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1478-3231.2011.02550.x","article-title":"Noncirrhotic hyperammonaemic encephalopathy","volume":"31","author":"Laish","year":"2011","journal-title":"Liver International"},{"key":"10.1016\/j.rmcr.2018.05.026_bib6","doi-asserted-by":"crossref","unstructured":"Cheng, Minfeng et al. Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012. Compr. Psychiatr., Volume 54, Issue 5, 562\u2013567.","DOI":"10.1016\/j.comppsych.2012.11.001"},{"key":"10.1016\/j.rmcr.2018.05.026_bib7","doi-asserted-by":"crossref","unstructured":"Lewis, Chandani et al. Valproate-induced hyperammonemic encephalopathy in general hospital patients with one or more psychiatric disorders. Psychosomatics, Volume 58, Issue 4, 415\u2013420.","DOI":"10.1016\/j.psym.2017.02.003"},{"key":"10.1016\/j.rmcr.2018.05.026_bib8","doi-asserted-by":"crossref","unstructured":"Maldonado C., Guevara N, et al. L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: a case report J. Int. Med. Res.: Vol 45, Issue 3, pp. 1268\u20131272.","DOI":"10.1177\/0300060517703278"},{"key":"10.1016\/j.rmcr.2018.05.026_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/217269","article-title":"Hyperammonemia associated with valproic acid concentrations","volume":"2014","author":"V\u00e1zquez","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"39","key":"10.1016\/j.rmcr.2018.05.026_bib10","doi-asserted-by":"crossref","first-page":"e8117","DOI":"10.1097\/MD.0000000000008117","article-title":"Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically healthy bipolar patient: essential review of the literature and case report","volume":"96","author":"Cattaneo","year":"2017","journal-title":"Medicine"},{"issue":"02","key":"10.1016\/j.rmcr.2018.05.026_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijep.2017.09.002","article-title":"A fatal case of valproate-induced hyperammonemic encephalopathy: an update on proposed pathogenic mechanisms and treatment options","volume":"04","author":"Yeung","year":"2017","journal-title":"Int. J. Epilepsy"},{"issue":"11","key":"10.1016\/j.rmcr.2018.05.026_bib12","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/MD.0000000000000066","article-title":"Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy","volume":"93","author":"Tseng","year":"2014","journal-title":"Medicine"},{"key":"10.1016\/j.rmcr.2018.05.026_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/0028-3886.198192","article-title":"How to recognize and treat metabolic encephalopathy in Neurology intensive care unit","volume":"65","author":"Berisavac","year":"2017","journal-title":"Neurol. India"},{"issue":"01","key":"10.1016\/j.rmcr.2018.05.026_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2193-1801-2-13","article-title":"Valproic acid-induced hyperammonemic encephalopathy \u2212 a potentially fatal adverse drug reaction","volume":"2","author":"Sousa","year":"2013","journal-title":"SpringerPlus"}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007118301400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007118301400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T15:53:00Z","timestamp":1566748380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007118301400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":14,"alternative-id":["S2213007118301400"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2018.05.026","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxic respiratory failure due to hyperammonemic encephalopathy induced by concurrent use of valproic acid and topiramate, a case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2018.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}